Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Bone Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Not applicableActive Not RecruitingNCT05101824
What this trial is testing

Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease

Who this might be right for
Oligometastatic DiseaseBone MetastasesStereotactic Body Radiotherapy
Gitte Fredberg Persson MD PhD 67
Early research (Phase 1)WithdrawnNCT05010096
What this trial is testing

BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the BoneMetastatic Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT01501630
What this trial is testing

Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer

Who this might be right for
Prostate Cancer
Assistance Publique - Hôpitaux de Paris 112
Testing effectiveness (Phase 2)Study completedNCT00003336
What this trial is testing

Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Case Comprehensive Cancer Center 6
Early research (Phase 1)Study completedNCT00005634
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00114257
What this trial is testing

Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Not Yet RecruitingNCT06221072
What this trial is testing

Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid

Who this might be right for
Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors
Shanghai JMT-Bio Inc. 1,360
Not applicableStudy completedNCT00412139
What this trial is testing

Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis Patients

Who this might be right for
Chronic Renal Failure
University of Skopje 100
Not applicableStudy completedNCT00899665
What this trial is testing

Proteases in Patients With Prostate Cancer That Has Spread to the Bone

Who this might be right for
AnemiaMetastatic CancerMyelodysplastic Syndromes+2 more
Barbara Ann Karmanos Cancer Institute 31
Not applicableUnknownNCT03908853
What this trial is testing

Pain Phenotyping of Patients With Bone Cancer Pain

Who this might be right for
PainBone MetastasesMetastatic Breast Cancer
University of Copenhagen 70
Testing effectiveness (Phase 2)WithdrawnNCT01101412
What this trial is testing

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersInfectionLeukemia+6 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00534430
What this trial is testing

Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00004145
What this trial is testing

Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Chicago 16
Early research (Phase 1)Study completedNCT00958477
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Who this might be right for
Prostate CancerBone Metastases
Merck KGaA, Darmstadt, Germany 26
Large-scale testing (Phase 3)Study completedNCT02561039
What this trial is testing

Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Who this might be right for
Pain; Bone Neoplasms; Neoplasm Metastasis
Hoffmann-La Roche 97
Post-approval studies (Phase 4)Study completedNCT00099541
What this trial is testing

Non-small Cell Lung Cancer Registry

Who this might be right for
Non-Small-Cell Lung CancerPleural Effusion, Malignant
Novartis Pharmaceuticals 300
Early research (Phase 1)Study completedNCT00107354
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06538896
What this trial is testing

Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical Study

Who this might be right for
Triple-negative Breast CancerBone Metastases
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00014469
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center
Next Page